Alzheimer’s disease:
let’s focus on intestinal microbiome!

Q&T Research is participating in a study which is evaluating an investigational drug for people diagnosed with mild to moderate Alzheimer’s disease (AD). The research drug is designed to restore the natural balance of bacteria in the intestine. It is believed that certain bacteria are responsible for the inflammation of the brain and nerves, which may contribute to AD.

We are looking for people who:

  • Are between the ages of 50 and 85;
  • Have been diagnosed with mild to moderate Alzheimer’s disease (AD).

This study is under the medical supervision of Dr. Paule Royer.

Monetary compensation will be provided for participants in this clinical study.

For more information, please contact the Q&T Research team at 819-562-0777 or visit www.qtrecherche.com.

Let us move science forward together.